J&J's Sales Plan Caused Opioid Addiction, Okla. Judge Hears
Law360 (June 11, 2019, 10:57 PM EDT) -- Johnson & Johnson’s promotion of its fentanyl patch Duragesic for long-term use would have caused patients to develop “the devastating disease of addiction,” an opioid expert from Brandeis University testified in Oklahoma's case against drugmakers Tuesday.
A pharmacist holds a Duragesic patch, middle, and two other fentanyl patches. (AP)
During the third week of the trailblazing bench trial before Judge Thad Balkman, Oklahoma called to the stand Dr. Andrew Kolodny, the co-director of opioid policy research at Brandeis and executive director of the organization Physicians for Responsible Opioid Prescribing.
Under examination by Bradley Beckworth of Nix Patterson LLP, representing the state,...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!